DoMore Diagnostics
Company Overview
DoMore Diagnostics is a precision medicine company focused on personalized cancer treatment delivered with AI technology. Their mission is to develop novel diagnostic methods based on artificial intelligence to enable personalized cancer treatment, improve patient outcomes, and reduce healthcare costs worldwide. The company is based on prominent research from leading institutions such as Oslo University Hospital, Oxford University, and University College London. It was selected as a Lighthouse project by the Norwegian Research Council, aiming to utilize AI technology in digital pathology to reduce over- and undertreatment in cancer.
Management Team
Torbjørn Furuseth, MD - CEO & Co-founder with a background in radiology, sports medicine, and experience in business and innovation leadership.
Sepp De Raedt, PhD - CTO & Co-founder experienced in machine learning and AI in diagnostic methods.
Elisabeth M.J. Klaussen, MSc - Head of Quality and Regulatory with extensive quality assurance experience.
Andreas Berg Storsve, PhD - VP Operations with expertise in life sciences business and R&D.
Lao Saal, MD, PhD - Medical Director, cancer scientist, and entrepreneur focused on advancing cancer research.
Sepp De Raedt, PhD - CTO & Co-founder experienced in machine learning and AI in diagnostic methods.
Elisabeth M.J. Klaussen, MSc - Head of Quality and Regulatory with extensive quality assurance experience.
Andreas Berg Storsve, PhD - VP Operations with expertise in life sciences business and R&D.
Lao Saal, MD, PhD - Medical Director, cancer scientist, and entrepreneur focused on advancing cancer research.